Page 11 - Haematologica Vol. 110 - January 2025
P. 11
LANDMARK PAPER IN HEMATOLOGY
L. Ysebaert
References
1. Vardi N. For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug. WW Norton & Co., 2023.
2. Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32-42.
3. Byrd JC, Furman RR, Coutre SE, et al. Ibrutinib treatment for first-line and relapsed/refractory chronic lymphocytic leukemia: final analysis of the pivotal phase Ib/II PCYC-1102 study. Clin Cancer Res. 2020;26(15):3918-3927.
Haematologica | 110 January 2025
3
